Published in Cancers (Basel) on April 15, 2015
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA (2011) 7.61
Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev (2004) 5.89
Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66
A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst (2003) 3.29
Melanoma and sun exposure: an overview of published studies. Int J Cancer (1997) 2.65
Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis. Br J Dermatol (2014) 2.15
The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr (2000) 1.68
Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res (2011) 1.49
Pigmentary characteristics and moles in relation to melanoma risk. Int J Cancer (2005) 1.40
Malignant melanoma in organ allograft recipients. Transplantation (1996) 1.22
Acne and risk of prostate cancer. Int J Cancer (2007) 1.11
Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. Eur J Cancer (2012) 1.07
Associations between testosterone levels and incident prostate, lung, and colorectal cancer. A population-based study. Cancer Epidemiol Biomarkers Prev (2012) 0.98
Androgen receptor interacts with telomeric proteins in prostate cancer cells. J Biol Chem (2010) 0.97
Systematic review of melanoma incidence and prognosis in solid organ transplant recipients. Transplant Res (2014) 0.96
Estimating the attributable fraction for melanoma: a meta-analysis of pigmentary characteristics and freckling. Int J Cancer (2010) 0.94
Malignant melanoma: an androgen-dependent tumour? Lancet (1980) 0.89
Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer. Arch Dermatol (2011) 0.89
Risk of subsequent primary cancer among prostate cancer patients in Bavaria, Germany. Eur J Cancer Prev (2012) 0.86
Androgen blockade enhances response to melanoma vaccine. J Surg Res (2003) 0.86
Photoperiod and testosterone modulate growth and melanogenesis of s91 murine melanoma. Med Chem (2008) 0.85
Personal history of prostate cancer and increased risk of incident melanoma in the United States. J Clin Oncol (2013) 0.83
Structural and functional association of androgen receptor with telomeres in prostate cancer cells. Aging (Albany NY) (2013) 0.83
Melanoma in organ transplant recipients: the old enemy finds a new battleground. Australas J Dermatol (2007) 0.83
Melanoma. Facial Plast Surg Clin North Am (2013) 0.79
Melanoma of non-sun exposed skin in a man with previous prostate cancer: recognition of a recently confirmed association. Dermatol Ther (Heidelb) (2014) 0.78